Attenuated Psychosis Syndrome Should be Moved to the Main Section in DSM-5-TR.

Scott W. Woods , Vijay A. Mittal , Cheryl M. Corcoran
JAMA Psychiatry

3
2021
White matter changes in psychosis risk relate to development and are not impacted by the transition to psychosis.

Barbara A. Cornblatt , Barbara A. Cornblatt , Alan Anticevic , Sylvain Bouix
Molecular Psychiatry 1 -12

2021
Aripiprazole in the treatment of the psychosis prodrome: an open-label pilot study

Jennifer L. Callahan , Shuki J. Cohen , Daniel H. Mathalon , Tandy J. Miller
The British journal of psychiatry. Supplement 191 ( 51)

133
2007
Quantitative analysis of sponsorship bias in economic studies of antidepressants

C. Bruce Baker , Michael T. Johnsrud , M. Lynn Crismon , Robert A. Rosenheck
British Journal of Psychiatry 183 ( 6) 498 -506

136
2003
Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis.

David R. Goldsmith , Ebrahim Haroon , Andrew H. Miller , Jean Addington
Brain Behavior and Immunity 76 268 -274

21
2019
Equivalent mismatch negativity deficits across deviant types in early illness schizophrenia-spectrum patients.

Rachel A. Hay , Brian J. Roach , Vinod H. Srihari , Scott W. Woods
Biological Psychology 105 130 -137

33
2015
Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial.

David H. Barlow , Jack M. Gorman , M. Katherine Shear , Scott W. Woods
JAMA 283 ( 19) 2529 -2536

1,558
2000
Clinical phenomenology of the prodrome for psychosis

Albert R. Powers III , Thomas H. McGlashan , Scott W. Woods
Oxford University Press 105 -112

2
2020
76. fMRI Response During Error Processing in Clinical High Risk and Early Illness Schizophrenia

Susanna Fryer , Jennifer D. Townsend , Judith M. Ford , Brian J. Roach
Schizophrenia Bulletin 43

2017
209. Risk of Violence in Attenuated Psychosis Symptoms Syndrome and its Relationship With Symptomology.

Heline Mirzakhanian , Sandra Sanchez , Jean Addington , Carrie Bearden
Schizophrenia Bulletin 43

2017
M118. Functional Capacity: A New Predictor of Role Functioning in Individuals at Clinical High Risk for Psychosis

Ricardo Carrion , Danielle McLaughlin , Andrea Auther , Jean Addington
Schizophrenia Bulletin 43

2017
Towards a Psychosis Risk Blood Diagnostic for Persons Experiencing High-Risk Symptoms: Preliminary Results From the NAPLS Project

Diana O. Perkins , Clark D. Jeffries , Jean Addington , Carrie E. Bearden
Schizophrenia Bulletin 41 ( 2) 419 -428

203
2015
Specificity of Incident Diagnostic Outcomes in Patients at Clinical High Risk for Psychosis

Jadon R. Webb , Jean Addington , Diana O. Perkins , Carrie E. Bearden
Schizophrenia Bulletin 41 ( 5) 1066 -1075

58
2015
The Dark Side of the Moon: Meta-analytical Impact of Recruitment Strategies on Risk Enrichment in the Clinical High Risk State for Psychosis

Paolo Fusar-Poli , Frauke Schultze-Lutter , Marco Cappucciati , Grazia Rutigliano
Schizophrenia Bulletin 42 ( 3) 732 -743

228
2016
Functional Capacity Assessed by the Map Task in Individuals at Clinical High-Risk for Psychosis

Danielle McLaughlin , Ricardo E. Carrión , Andrea M. Auther , Doreen M. Olvet
Schizophrenia Bulletin 42 ( 5) 1234 -1242

14
2016
The Role of Cognition and Social Functioning as Predictors in the Transition to Psychosis for Youth With Attenuated Psychotic Symptoms

Jean Addington , Lu Liu , Diana O. Perkins , Ricardo E. Carrion
Schizophrenia Bulletin 43 ( 1) 57 -63

50
2017
Mechanisms of change in cognitive behavioral therapy for panic disorder: the unique effects of self-efficacy and anxiety sensitivity.

Matthew W. Gallagher , Laura A. Payne , Kamila S. White , Katherine M. Shear
Behaviour Research and Therapy 51 ( 11) 767 -777

74
2013
Therapist effects and the outcome-alliance correlation in cognitive behavioral therapy for panic disorder with agoraphobia.

Jonathan D. Huppert , Yogev Kivity , David H. Barlow , Jack M. Gorman
Behaviour Research and Therapy 52 ( 1) 26 -34

34
2014
Cognitive behavior therapy for early psychosis: a comprehensive review of individual vs. group treatment studies.

John R. Saksa , Shuki J. Cohen , Vinod H. Srihari , Scott W. Woods
International Journal of Group Psychotherapy 59 ( 3) 357 -383

38
2009
Platelet alpha-2-receptor binding and adenylate cyclase activity in panic disorder.

Dennis S. Charney , Robert B. Innis , Ronald S. Duman , Scott W. Woods
Psychopharmacology 98 ( 1) 102 -107

32
1989